OSUR Insider Trading
ORASURE TECHNOLOGIES INC | Surgical & Medical Instruments & Apparatus
Comprehensive Trading Performance Summary
The investment history of corporate insiders at ORASURE TECHNOLOGIES INC provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-23 23:23 | 2026-03-20 | EGLINTON MANNER CARRIE | Director, Officer - President & CEO | BUY | $2.93 | 32,300 | $94,597 | 2,190,874 | +1.5% |
| 2026-03-23 23:23 | 2026-03-20 | McGrath Kenneth J | Officer - Chief Financial Officer | BUY | $2.93 | 32,300 | $94,600 | 589,562 | +5.8% |
| 2026-03-17 00:01 | 2026-03-13 | McGrath Kenneth J | Officer - Chief Financial Officer | BUY | $3.00 | 22,021 | $66,030 | 557,262 | +4.1% |
| 2026-03-17 00:01 | 2026-03-13 | EGLINTON MANNER CARRIE | Director, Officer - President & CEO | BUY | $3.00 | 22,022 | $66,033 | 2,158,574 | +1.0% |
| 2025-12-03 00:16 | 2025-11-28 | Gagliano Nancy J | Director | BUY | $2.37 | 2,100 | $4,982 | 160,254 | +1.3% |
| 2025-03-03 17:08 | 2025-02-27 | Gagliano Nancy J | Director | BUY | $3.08 | 12,750 | $39,270 | 91,524 | +16.2% |
| 2025-03-03 17:07 | 2025-02-28 | EGLINTON MANNER CARRIE | Director, Officer - President & CEO | BUY | $3.49 | 28,670 | $100,027 | 1,288,334 | +2.3% |
| 2025-02-28 05:14 | 2025-02-27 | EGLINTON MANNER CARRIE | Director, Officer - President & CEO | BUY | $3.15 | 78,625 | $247,378 | 1,259,664 | +6.7% |
| 2025-02-28 05:14 | 2025-02-27 | Kenny John P. | Director | BUY | $3.17 | 47,659 | $151,217 | 70,915 | +204.9% |
| 2025-02-28 05:14 | 2025-02-27 | McGrath Kenneth J | Officer - Chief Financial Officer | BUY | $3.15 | 64,000 | $201,683 | 371,013 | +20.8% |
| 2025-02-28 00:19 | 2025-02-27 | Marmora Lelio | Director | BUY | $3.06 | 7,000 | $21,420 | 67,720 | +11.5% |
| 2023-12-22 00:04 | 2023-12-19 | Weber Kathleen Gallagher | Officer - Chief Product Officer | OPT+S | $8.05 | 24,129 | $194,219 | 254,700 | 0.0% |
| 2023-08-17 23:27 | 2023-08-15 | Anthony Michele Marie | Officer - SVP Finance & CAO | OPT+S | $6.50 | 1,758 | $11,427 | 86,188 | 0.0% |
| 2023-05-31 23:14 | 2023-05-30 | McGrath Kenneth J | Officer - Chief Financial Officer | BUY | $4.93 | 100,000 | $492,810 | 285,512 | +53.9% |
| 2022-08-31 15:42 | 2022-08-25 | Aspinall Mara G. | Director | BUY | $4.19 | 6,000 | $25,138 | 77,218 | +8.4% |
| 2022-08-30 00:08 | 2022-08-26 | LANCASTER RONNY B | Director | BUY | $4.00 | 50,000 | $200,000 | 104,782 | +91.3% |
| 2022-08-23 01:54 | 2022-08-17 | Gagliano Nancy J | Director | BUY | $4.39 | 2,200 | $9,658 | 42,160 | +5.5% |
| 2022-08-16 23:01 | 2022-08-12 | Celano Michael | Director | BUY | $4.49 | 12,000 | $53,916 | 111,823 | +12.0% |
| 2021-01-05 01:48 | 2020-12-23 | Weber Kathleen Gallagher | Officer - EVP & BU Lead - Molecular | SELL | $11.76 | 10,000 | $117,600 | 96,544 | -9.4% |
| 2019-05-14 23:44 | 2019-05-14 | TANG STEPHEN S PHD | Officer - President and CEO | BUY | $8.56 | 1,000 | $8,560 | 119,960 | +0.8% |
| 2019-05-14 23:41 | 2019-05-13 | JERRETT JACK E | Officer - SVP & General Counsel | BUY | $8.55 | 10,000 | $85,487 | 91,885 | +12.2% |
| 2019-05-14 23:38 | 2019-05-10 | Cuca Roberto | Officer - CFO | BUY | $9.03 | 10,000 | $90,314 | 47,575 | +26.6% |
| 2019-04-03 23:29 | 2019-04-01 | TANG STEPHEN S PHD | Officer - President and CEO | OPT+S | $11.10 | 16,667 | $185,015 | 118,960 | 0.0% |
| 2018-08-30 00:00 | 2018-08-27 | Patrick Charles W | Director | SELL | $16.29 | 8,000 | $130,320 | 54,298 | -12.8% |
| 2018-02-21 01:40 | 2018-02-15 | SMITH BRIAN | Officer - EVP & BU Lead - Molecular | OPT+S | $17.97 | 20,000 | $359,460 | 18,075 | 0.0% |
| 2018-02-21 01:38 | 2018-02-15 | TANG STEPHEN S PHD | Director | OPT+S | $17.97 | 23,333 | $419,247 | 36,416 | 0.0% |
| 2017-11-10 01:11 | 2017-11-07 | Aspinall Mara G. | Director | BUY | $14.23 | 5,000 | $71,164 | 5,000 | +100.0% |
| 2017-10-06 23:44 | 2017-10-04 | Michels Douglas A | Director, Officer - President & CEO | SELL | $23.00 | 22,923 | $527,229 | 720,135 | -3.1% |
| 2017-10-04 00:07 | 2017-09-29 | Michels Douglas A | Director, Officer - President & CEO | SELL | $22.55 | 25,000 | $563,713 | 743,058 | -3.3% |
| 2017-09-05 23:00 | 2017-08-31 | SMITH BRIAN | Officer - See Remarks | OPT+S | $20.47 | 9,112 | $186,515 | 23,365 | 0.0% |
| 2017-08-31 23:05 | 2017-08-30 | Patrick Charles W | Director | SELL | $20.11 | 1,000 | $20,110 | 51,104 | -1.9% |
| 2017-08-24 23:05 | 2017-08-22 | SMITH BRIAN | Officer - SEE REMARKS | SELL | $21.09 | 3,075 | $64,864 | 23,465 | -11.6% |
| 2017-08-09 23:52 | 2017-08-07 | Zezzo II Anthony | Officer - EVP - Infectious Diseases | OPT+S | $21.26 | 72,916 | $1,550,296 | 145,410 | 0.0% |
| 2017-08-09 00:38 | 2017-08-04 | SPAIR RONALD H | Director, Officer - COO & CFO | OPT+S | $20.66 | 510,112 | $10,537,435 | 109,066 | 0.0% |
| 2017-08-09 00:36 | 2017-08-04 | KUNA MARK L | Officer - SVP & Controller | OPT+S | $20.49 | 61,959 | $1,269,366 | 48,491 | 0.0% |
| 2017-08-09 00:35 | 2017-08-07 | JERRETT JACK E | Officer - SVP & General Counsel | OPT+S | $20.77 | 73,463 | $1,525,650 | 49,219 | 0.0% |
| 2017-06-30 02:49 | 2017-06-27 | Michels Douglas A | Director, Officer - President & CEO | OPT+S | $16.75 | 290,495 | $4,866,256 | 768,058 | 0.0% |
| 2017-05-30 23:56 | 2017-05-30 | Patrick Charles W | Director | SELL | $15.15 | 6,666 | $100,990 | 52,104 | -11.3% |
| 2017-05-30 23:55 | 2017-05-26 | LANCASTER RONNY B | Director | OPT+S | $14.79 | 89,684 | $1,326,373 | 6,295 | 0.0% |
| 2017-05-12 00:30 | 2017-05-10 | Zezzo II Anthony | Officer - EVP, Marketing and Sales | OPT+S | $14.70 | 115,000 | $1,690,845 | 145,410 | 0.0% |
| 2017-05-12 00:29 | 2017-05-09 | Michels Douglas A | Director, Officer - President & CEO | OPT+S | $15.01 | 209,800 | $3,149,098 | 768,058 | 0.0% |
| 2017-05-10 01:53 | 2017-05-05 | SPAIR RONALD H | Director, Officer - COO & CFO | OPT+S | $15.00 | 72,564 | $1,088,656 | 109,066 | 0.0% |
| 2017-05-10 01:50 | 2017-05-05 | PRINGLE ROGER L | Director | OPT+S | $14.93 | 140,552 | $2,098,863 | 76,452 | 0.0% |
| 2017-05-10 01:49 | 2017-05-05 | Patrick Charles W | Director | SELL | $14.96 | 10,000 | $149,600 | 56,881 | -15.0% |
| 2017-05-10 01:48 | 2017-05-05 | Michels Douglas A | Director, Officer - President & CEO | OPT+S | $15.08 | 361,216 | $5,447,354 | 768,058 | 0.0% |
| 2017-05-10 01:46 | 2017-05-05 | KUNA MARK L | Officer - SVP & Controller | OPT+S | $15.11 | 36,413 | $550,018 | 63,491 | 0.0% |
| 2017-05-10 01:45 | 2017-05-05 | Celano Michael | Director | SELL | $14.95 | 44,962 | $672,182 | 38,117 | -54.1% |
| 2017-03-23 23:41 | 2017-03-21 | TANG STEPHEN S PHD | Director | SELL | $12.00 | 220 | $2,640 | 31,748 | -0.7% |
| 2017-03-07 01:05 | 2017-03-02 | Celano Michael | Director | OPT+S | $12.00 | 15,000 | $180,000 | 83,079 | 0.0% |
| 2017-03-07 01:02 | 2017-03-02 | TANG STEPHEN S PHD | Director | SELL | $12.02 | 6,100 | $73,346 | 31,968 | -16.0% |
How to Interpret $OSUR Trades
Not every insider transaction in ORASURE TECHNOLOGIES INC is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $OSUR shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for OSUR
Insider activity data for ORASURE TECHNOLOGIES INC is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $OSUR, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.